pembrolizumab
merck
['biomarker', 'kn158', 'marker ']
 argues that tmb as an agnostic biomarker lacks data (weak data from kn158) and is "faith" based at the moment. #esmo2022 
Enjoying oncology, without meaning to sound too cynical